{
  "authors": [
    {
      "author": "Gustavo Schvartsman"
    },
    {
      "author": "Kristen Perez"
    },
    {
      "author": "Jill E Flynn"
    },
    {
      "author": "Jeffrey N Myers"
    },
    {
      "author": "Hussein Tawbi"
    }
  ],
  "doi": "10.1186/s40425-017-0250-5",
  "publication_date": "2017-06-24",
  "id": "EN113994",
  "url": "https://pubmed.ncbi.nlm.nih.gov/28642816",
  "source": "Journal for immunotherapy of cancer",
  "source_url": "",
  "licence": "CC BY-NC",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "Here we present the case of a patient with recurrent locally advanced cutaneous melanoma receiving salvage T-VEC therapy in the setting of orthotropic heart transplantation. After 5 cycles of therapy, no evidence of graft rejection has been observed to date, and the patient achieved a complete remission, and is currently off therapy."
}